Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CDXS Codexis Inc
- Stocks
- Healthcare
- NASDAQ: CDXS
Price (delayed)
$2.64
Market cap
$218.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.89
Enterprise value
$257.76M
Highlights
CDXS's quick ratio has surged by 59% year-on-year and by 27% since the previous quarter
The EPS is up by 21% year-on-year but it has declined by 2.3% since the previous quarter
The company's net income rose by 14% YoY but it fell by 5% QoQ
The debt has grown by 43% from the previous quarter
Codexis's gross profit has decreased by 25% YoY and by 12% QoQ
Key stats
What are the main financial stats of CDXS
Market
Valuations
Earnings
Shares outstanding
82.84M
Market cap
$218.69M
Enterprise value
$257.76M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.21
Price to sales (P/S)
3.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.34
Revenue
$59.35M
Gross profit
$43.06M
Operating income
-$58.52M
Net income
-$65.28M
EBIT
-$54.85M
EBITDA
-$46.72M
Free cash flow
-$53.63M
Per share
Balance sheet
Liquidity
EPS
-$0.89
EPS diluted
-$0.89
Free cash flow per share
-$0.73
Book value per share
$0.82
Revenue per share
$0.81
TBVPS
$2
Total assets
$149.01M
Total liabilities
$82.08M
Debt
$59.9M
Equity
$66.93M
Working capital
$75.12M
Debt to equity
0.89
Current ratio
4.18
Quick ratio
3.79
Net debt/EBITDA
-0.84
Margins
Efficiency
Dividend
EBITDA margin
-78.7%
Gross margin
72.6%
Net margin
-110%
Operating margin
-98.6%
Return on assets
-45.1%
Return on equity
-92.9%
Return on invested capital
-44%
Return on capital employed
-43.8%
Return on sales
-92.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CDXS stock price
How has the Codexis stock price performed over time
Intraday
7.32%
1 week
5.18%
1 month
12.34%
1 year
-27.07%
YTD
-44.65%
QTD
-1.86%
Financial performance
How have Codexis's revenue and profit performed over time
Revenue
$59.35M
Gross profit
$43.06M
Operating income
-$58.52M
Net income
-$65.28M
Gross margin
72.6%
Net margin
-110%
Codexis's gross profit has decreased by 25% YoY and by 12% QoQ
The operating margin has declined by 25% since the previous quarter
The company's operating income fell by 15% QoQ but it rose by 14% YoY
CDXS's revenue is down by 15% year-on-year and by 8% since the previous quarter
Price vs fundamentals
How does CDXS's price correlate with its fundamentals
Growth
What is Codexis's growth rate over time
Valuation
What is Codexis stock price valuation
P/E
N/A
P/B
3.21
P/S
3.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.34
The EPS is up by 21% year-on-year but it has declined by 2.3% since the previous quarter
CDXS's price to book (P/B) is 41% lower than its 5-year quarterly average of 5.4 and 18% lower than its last 4 quarters average of 3.9
The equity has declined by 23% year-on-year and by 9% since the previous quarter
The price to sales (P/S) is 61% lower than the 5-year quarterly average of 8.3 and 20% lower than the last 4 quarters average of 4.1
CDXS's revenue is down by 15% year-on-year and by 8% since the previous quarter
Efficiency
How efficient is Codexis business performance
The company's return on invested capital rose by 43% YoY and by 12% QoQ
Codexis's return on equity has decreased by 30% YoY and by 12% QoQ
The return on sales has declined by 25% since the previous quarter
Codexis's return on assets has decreased by 6% YoY and by 2.7% QoQ
Dividends
What is CDXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CDXS.
Financial health
How did Codexis financials performed over time
CDXS's total assets is 82% greater than its total liabilities
The total liabilities has surged by 64% year-on-year and by 10% since the previous quarter
Codexis's current ratio has surged by 60% YoY and by 30% QoQ
The debt is 11% less than the equity
The company's debt to equity has surged by 56% QoQ
The debt has grown by 43% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.